International Annual Meeting on Breakthroughs in breast cancer research and treatment

Come and meet the APIS team to discover the:

The APIS Breast Cancer Subtyping Kit is a highly reproducible, RT-qPCR based IVD product (in certain territories) and RUO product for detecting standard (HER2, ER, PR, Ki67) and novel proliferative biomarkers. This assay can help direct clinicians to the right treatment more quickly with higher accuracy.
The APIS ESR1 Mutations Kit is an advanced qPCR assay for the sensitive and precise detection of mutations within the estrogen receptor gene. The Kit is a qualitative test, detecting eleven ESR1 mutations across exons 5 (E380Q), 7 (S463P) and 8 (P535H, L536R, L536Q, L536H, L536P, Y537C, Y537S, Y537N and D538G).
The new APIS PIK3CA Mutations Kit is a real-time qualitative PCR test for the detection of the five most prevalent activating mutations in the PIK3CA gene, using a sample of DNA extracted from either formalin-fixed, paraffin-embedded (FFPE) breast tumour tissue or blood plasma (cfDNA).
The APIS MET Alterations Kit is a RT-qPCR assay detecting both MET exon 14 skipping mutation and MET gene overexpression.
The new ESR1 dPCR Kit is a dPCR assay detecting 11 key mutations within the oestrogen receptor gene.

Use this link to contact us and schedule a meeting.

8th World Congress on Controversies in Breast Cancer